Improvements in Signs and Symptoms During Hospitalization for Acute Heart Failure Follow Different Patterns and Depend on the Measurement Scales Used: An International, Prospective Registry to Evaluate the Evolution of Measures of Disease Severity in Acute Heart Failure (MEASURE-AHF)

Journal of Cardiac Failure

Volumn 14, Issue 9, 2008, Pages 777-784

  Allen, Larry A ^a   Metra, Marco ^b   Milo Cotter, Olga ^c   Filippatos, Gerasimos ^d   Reisin, Leonardo H ^e   Bensimhon, Daniel R ^f   Gronda, Edoardo G ^g   Colombo, Paolo ^h   Felker, G Michael ^c   Cas, Livio Dei ^b   Kremastinos, Dimitrios T ^d   O'connor, Christopher M ^b   Cotter, Gadi ⁱ   Davison, Beth A ⁱ   Dittrich, Howard C ^j   Velazquez, Eric J ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^e BARZILAI MEDICAL CENTER   (Israel)

^f MOSES CONE HEALTH SYSTEM   (United States)

^g HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^h NewYork Presbyterian Hospital   (United States)

ⁱ Momentum Research Inc   (United States)

^j Sequel Pharmaceuticalsm Inc   (United States)

more..

Author keywords

Congestive heart failure; dyspnea; end point determination; exacerbation; physical examination; treatment outcome

Indexed keywords

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL FEATURE; DEFIBRILLATOR; DISEASE SEVERITY; DYSPNEA; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; VISUAL ANALOG SCALE;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HEART FAILURE; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; PATIENT ADMISSION; PATIENT DISCHARGE; PROSPECTIVE STUDIES; REGISTRIES; SEVERITY OF ILLNESS INDEX; WEIGHTS AND MEASURES;

EID: 55149109241     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.07.188     Document Type: Article

References (32)

1. McCullough P.A., Philbin E.F., Spertus J.A., Kaatz S., Sandberg K.R., and Weaver W.D. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 39 (2002) 60-69
2. Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. Section 12: evaluation and management of patients with acute decompensated heart failure. J Cardiac Fail 12 (2006) e86-103
3. Nieminen M.S., Bohm M., Cowie M.R., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 384-416
4. Gheorghiade M., Zannad F., Sopko G., et al. Acute heart failure syndromes: current state and framework for future research. Circulation 112 (2005) 3958-3968
5. Ramirez A., and Abelmann W.H. Cardiac decompensation. N Engl J Med 290 (1974) 499-501
6. Levy D., Kenchaiah S., Larson M.G., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347 (2002) 1397-1402
7. Colucci W.S., Elkayam U., Horton D.P., et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 343 (2000) 246-253
8. Burger A.J., Horton D.P., LeJemtel T., et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J 144 (2002) 1102-1108
9. Gheorghiade M., Gattis W.A., Adams Jr. K.F., Jaffe A.S., and O'Connor C.M. Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF). Am Heart J 145 2 Suppl (2003) S55-S57
10. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 287 (2002) 1531-1540
11. Cuffe M.S., Califf R.M., Adams Jr. K.F., et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 287 (2002) 1541-1547
12. The Escape Investigators and Escape Study Coordinators. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness: the ESCAPE Trial. JAMA 294 (2005) 1625-1633
13. Gattis W.A., O'Connor C.M., Gallup D.S., Hasselblad V., and Gheorghiade M. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. J Am Coll Cardiol 43 (2004) 1534-1541
14. Mebazaa A., Nieminen M.S., Packer M., et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 297 (2007) 1883-1891
15. Konstam M.A., Gheorghiade M., Burnett Jr. J.C., et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 297 (2007) 1319-1331
16. Teerlink J.R., McMurray J.J., Bourge R.C., et al. Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS). Am Heart J 150 (2005) 46-53
17. Allen L.A., and O'Connor C.M. Management of acute decompensated heart failure. CMAJ 176 (2007) 797-805
18. Teerlink J.R. Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure. Am Heart J 145 2 Suppl (2003) S26-S33
19. Heart Failure Society of America. HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 12 (2006) e1-e2
20. Adams Jr. K.F., Fonarow G.C., Emerman C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 (2005) 209-216
21. Givertz M.M., Massie B.M., Fields T.K., Pearson L.L., and Dittrich H.C. The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol 50 (2007) 1551-1560
22. Costanzo M.R., Guglin M.E., Saltzberg M.T., et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49 (2007) 675-683
23. Gheorghiade M., Konstam M.A., Burnett Jr. J.C., et al. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA 297 (2007) 1332-1343
24. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
25. Melloni C., Peterson E.D., Chen A.Y., et al. Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 51 (2008) 991-996
26. Pang P.S., Cleland J.G., Teerlink J.R., et al. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J 29 (2008) 816-824
27. Drazner M.H., Rame J.E., Stevenson L.W., and Dries D.L. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 345 (2001) 574-581
28. Turner J.A., Deyo R.A., Loeser J.D., Von Korff M., and Fordyce W.E. The importance of placebo effects in pain treatment and research. JAMA 271 (1994) 1609-1614
29. Walsh B.T., Seidman S.N., Sysko R., and Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 287 (2002) 1840-1847
30. Sackner-Bernstein J.D., Skopicki H.A., and Aaronson K.D. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111 (2005) 1487-1491
31. Sackner-Bernstein J.D., Kowalski M., Fox M., and Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 293 (2005) 1900-1905
32. Gheorghiade M., Abraham W.T., Albert N.M., et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 296 (2006) 2217-2226